NPC1L1 and Cholesterol Transport

Overview

Journal FEBS Lett

Specialty Biochemistry

Date 2010 Mar 24

PMID 20307540

Citations 80

Authors

Jenna L Betters

Liqing Yu

Affiliations

Soon will be listed here.

Abstract

The polytopic transmembrane protein, Niemann-Pick C1-Like 1 (NPC1L1), is enriched in the apical membrane of small intestine absorptive enterocytes where it mediates extracellular sterol transport across the brush border membrane. It is essential for intestinal sterol absorption and is the molecular target of ezetimibe, a potent cholesterol absorption inhibitor that lowers blood cholesterol in humans. NPC1L1 is also highly expressed in human liver. The hepatic function of NPC1L1 may be to limit excessive biliary cholesterol loss. NPC1L1-dependent sterol uptake seems to be a clathrin-mediated endocytic process and is regulated by cellular cholesterol content. Recently, NPC1L1 inhibition has been shown to have beneficial effects on components of the metabolic syndrome, such as obesity, insulin resistance, and fatty liver, in addition to atherosclerosis.

Citing Articles

Transport functions of intestinal lymphatic vessels.

Tso P, Bernier-Latmani J, Petrova T, Liu M Nat Rev Gastroenterol Hepatol. 2024; 22(2):127-145.

PMID: 39496888 DOI: 10.1038/s41575-024-00996-z.

Suppressive Effect of Coffee Leaves on Lipid Digestion and Absorption In Vitro.

Sansri V, Sroyraya M, Phisalprapa P, Yosboonruang A, Ontawong A, Saokaew S Foods. 2024; 13(15).

PMID: 39123636 PMC: 11312072. DOI: 10.3390/foods13152445.

Assessment of ability of AlphaMissense to identify variants affecting susceptibility to common disease.

Curtis D Eur J Hum Genet. 2024; 32(11):1419-1427.

PMID: 39097650 PMC: 11576984. DOI: 10.1038/s41431-024-01675-y.

Comparison of Statin With Ezetimibe Combination Therapy Versus Statin Monotherapy for Primary Prevention in Middle-Aged Adults.

Cha J, Hong S, Lim S, Kim J, Joo H, Park J Korean Circ J. 2024; 54(9):534-544.

PMID: 38956936 PMC: 11361771. DOI: 10.4070/kcj.2024.0036.

Limosilactobacillus fermentum TY-S11 ameliorates hypercholesterolemia via promoting cholesterol excretion and regulating gut microbiota in high-cholesterol diet-fed apolipoprotein E-deficient mice.

Deng Y, Wang J, Wang R, Wang Y, Shu X, Wang P Heliyon. 2024; 10(11):e32059.

PMID: 38882320 PMC: 11180314. DOI: 10.1016/j.heliyon.2024.e32059.

References

Lally S, Owens D, Tomkin G . The different effect of pioglitazone as compared to insulin on expression of hepatic and intestinal genes regulating post-prandial lipoproteins in diabetes. Atherosclerosis. 2006; 193(2):343-51. DOI: 10.1016/j.atherosclerosis.2006.09.031. View

Ge L, Wang J, Qi W, Miao H, Cao J, Qu Y . The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1. Cell Metab. 2008; 7(6):508-19. DOI: 10.1016/j.cmet.2008.04.001. View

Iyer S, Yao X, Crona J, Hoos L, Tetzloff G, Davis Jr H . Characterization of the putative native and recombinant rat sterol transporter Niemann-Pick C1 Like 1 (NPC1L1) protein. Biochim Biophys Acta. 2005; 1722(3):282-92. DOI: 10.1016/j.bbagen.2004.12.021. View

Chu B, Ge L, Xie C, Zhao Y, Miao H, Wang J . Requirement of myosin Vb.Rab11a.Rab11-FIP2 complex in cholesterol-regulated translocation of NPC1L1 to the cell surface. J Biol Chem. 2009; 284(33):22481-22490. PMC: 2755969. DOI: 10.1074/jbc.M109.034355. View

Labonte E, Howles P, Granholm N, Rojas J, Davies J, Ioannou Y . Class B type I scavenger receptor is responsible for the high affinity cholesterol binding activity of intestinal brush border membrane vesicles. Biochim Biophys Acta. 2007; 1771(9):1132-9. PMC: 2071925. DOI: 10.1016/j.bbalip.2007.03.002. View

Kastelein J, Akdim F, Stroes E, Zwinderman A, Bots M, Stalenhoef A . Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med. 2008; 358(14):1431-43. DOI: 10.1056/NEJMoa0800742. View

Weinglass A, Kohler M, Nketiah E, Liu J, Schmalhofer W, Thomas A . Madin-Darby canine kidney II cells: a pharmacologically validated system for NPC1L1-mediated cholesterol uptake. Mol Pharmacol. 2008; 73(4):1072-84. DOI: 10.1124/mol.107.043844. View

Davies J, Levy B, Ioannou Y . Evidence for a Niemann-pick C (NPC) gene family: identification and characterization of NPC1L1. Genomics. 2000; 65(2):137-45. DOI: 10.1006/geno.2000.6151. View

Nakamura K, Matsui T, Adachi H, Yamagishi S . Involvement of angiotensin II in intestinal cholesterol absorption. Pharmacol Res. 2009; 61(5):460-5. DOI: 10.1016/j.phrs.2009.12.002. View

10.

Hawes B, Oneill K, Yao X, Crona J, Davis Jr H, Graziano M . In vivo responsiveness to ezetimibe correlates with niemann-pick C1 like-1 (NPC1L1) binding affinity: Comparison of multiple species NPC1L1 orthologs. Mol Pharmacol. 2006; 71(1):19-29. DOI: 10.1124/mol.106.027896. View

11.

Mathur S, Watt K, Field F . Regulation of intestinal NPC1L1 expression by dietary fish oil and docosahexaenoic acid. J Lipid Res. 2006; 48(2):395-404. DOI: 10.1194/jlr.M600325-JLR200. View

12.

Temel R, Tang W, Ma Y, Rudel L, Willingham M, Ioannou Y . Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. J Clin Invest. 2007; 117(7):1968-78. PMC: 1888567. DOI: 10.1172/JCI30060. View

13.

Turley S, Dietschy J . Sterol absorption by the small intestine. Curr Opin Lipidol. 2003; 14(3):233-40. DOI: 10.1097/00041433-200306000-00002. View

14.

Brown J, Rudel L, Yu L . NPC1L1 (Niemann-Pick C1-like 1) mediates sterol-specific unidirectional transport of non-esterified cholesterol in McArdle-RH7777 hepatoma cells. Biochem J. 2007; 406(2):273-83. PMC: 1948962. DOI: 10.1042/BJ20070168. View

15.

Labonte E, Camarota L, Rojas J, Jandacek R, Gilham D, Davies J . Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1-/- mice. Am J Physiol Gastrointest Liver Physiol. 2008; 295(4):G776-83. PMC: 2575916. DOI: 10.1152/ajpgi.90275.2008. View

16.

Lalloyer F, Fievet C, Lestavel S, Torpier G, van der Veen J, Touche V . The RXR agonist bexarotene improves cholesterol homeostasis and inhibits atherosclerosis progression in a mouse model of mixed dyslipidemia. Arterioscler Thromb Vasc Biol. 2006; 26(12):2731-7. DOI: 10.1161/01.ATV.0000248101.93488.84. View

17.

Knopfel M, Davies J, Duong P, Kvaerno L, Carreira E, Phillips M . Multiple plasma membrane receptors but not NPC1L1 mediate high-affinity, ezetimibe-sensitive cholesterol uptake into the intestinal brush border membrane. Biochim Biophys Acta. 2007; 1771(9):1140-7. DOI: 10.1016/j.bbalip.2007.05.011. View

18.

Betters J, Yu L . Transporters as drug targets: discovery and development of NPC1L1 inhibitors. Clin Pharmacol Ther. 2009; 87(1):117-21. DOI: 10.1038/clpt.2009.209. View

19.

Kwon H, Abi-Mosleh L, Wang M, Deisenhofer J, Goldstein J, Brown M . Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol. Cell. 2009; 137(7):1213-24. PMC: 2739658. DOI: 10.1016/j.cell.2009.03.049. View

20.

Zuniga S, Molina H, Azocar L, Amigo L, Nervi F, Pimentel F . Ezetimibe prevents cholesterol gallstone formation in mice. Liver Int. 2008; 28(7):935-47. DOI: 10.1111/j.1478-3231.2008.01808.x. View